L-Cysteinesulfinic acid

Discontinued Product

L-Cysteinesulfinic acid (Cat. No. 0216) has been withdrawn from sale for commercial reasons.
Description: NMDA and mGlu agonist
Datasheet
Citations
Reviews
Literature (5)

Biological Activity for L-Cysteinesulfinic acid

L-Cysteinesulfinic acid is an agonist at mGlu1a and mGlu5a subtypes expressed in clonal RGT cell lines. Also agonist at NMDA and PLD-coupled mGlu receptors.

Technical Data for L-Cysteinesulfinic acid

M. Wt 153.15
Formula C3H7NO4S
Storage Desiccate at -20°C
CAS Number 1115-65-7
PubChem ID 1549098
InChI Key ADVPTQAUNPRNPO-REOHCLBHSA-N
Smiles [H][C@](N)(CS(O)=O)C(O)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for L-Cysteinesulfinic acid

Certificate of Analysis / Product Datasheet
Select another batch:

References for L-Cysteinesulfinic acid

References are publications that support the biological activity of the product.

Gorman and Griffiths (1994) Sulphur-containing excitatory amino acid-stimulated inositol phosphate formation in primary cultures of cerebellar granule cells is mediated predominately by N-MthD.-aspartate receptors. Neuroscience 59 299 PMID: 8008194

Kingston et al (1998) Sulphur-containing amino acids are agonists for group 1 metabotropic receptors expressed in clonal RGT cell lines. Neuropharmacology 37 277 PMID: 9681926

Mewett et al (1983) Pharmacology of the excitatory actions of sulphonic and sulphinic amino acids. CNS Receptors: From Molecular Pharmacology to Beha 163-174

View Related Products by Product Action

View all NMDA Receptor Agonists

Keywords: L-Cysteinesulfinic acid, L-Cysteinesulfinic acid supplier, NMDA, mGlur, agonists, Glutamate, Receptors, N-Methyl-D-Aspartate, iGluR, Ionotropic, Non-Selective, Metabotropic, Non-selective, mGlu, 0216, Tocris Bioscience

Citations for L-Cysteinesulfinic acid

Citations are publications that use Tocris products.

Currently there are no citations for L-Cysteinesulfinic acid.

Reviews for L-Cysteinesulfinic acid

There are currently no reviews for this product. Be the first to review L-Cysteinesulfinic acid and earn rewards!

Have you used L-Cysteinesulfinic acid?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Huntington's Disease Research Product Guide

Huntington's Disease Research Product Guide

This product guide provides a background to Huntington's disease research and lists around 100 products for the study of:

  • Somatic Instability
  • Proteolysis and Inclusion Bodies
  • Transcriptional Dysregulation
  • Mitochondrial Dysfunction
  • Nuclear-Cytoplasmic Transport Interference
  • Excitotoxicity
  • Stem Cells
Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Huntington's Disease Poster

Huntington's Disease Poster

Huntington's disease (HD) is a severe monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the effects of mutant huntingtin aggregation implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.